Roy Galvin insider trades

Open-market stock purchases and sales by Roy Galvin, EVP, Chief Commercial Officer at Haemonetics Corp, from SEC Form 4 filings since Nov 1, 2022.

Recent trades

DateStockTradeValue
May 15, 2026HAE Haemonetics CorpSold (not open market)$49.5K
May 15, 2026HAE Haemonetics CorpBought (not open market)—
Oct 31, 2025HAE Haemonetics CorpSold (not open market)$7.3K

Companies traded

  • HAE Haemonetics Corp: other filings, last May 15, 2026

Get free alerts when Roy Galvin files a new trade →